Amphastar Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $37.9M, a 45.3% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $167M, a 63.3% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $138M, a 50.5% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $91.4M, a 47.1% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $62.1M, a 4327% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $138M +$46.2M +50.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $91.4M +$29.3M +47.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $62.1M +$60.7M +4327% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $1.4M -$47.5M -97.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $48.9M +$54.7M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 -$5.74M -$9.39M -257% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $3.65M -$6.17M -62.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $9.82M +$12.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$2.79M +$7.91M +74% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$10.7M -$22.6M -190% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $11.9M -$6.23M -34.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $18.1M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.